CircHAS2 activates CCNE2 to promote cell proliferation and sensitizes the response of colorectal cancer to anlotinib - Li, Haosheng; Feng, Haoran; Zhang, Tao; Wu, Junwei; Shen, Xiaonan; Xu, Shuiyu; Xu, Lianghui; Wang, Shaodong; Zhang, Yaqi; Jia, Wenqing; Ji, Xiaopin; Cheng, Xi; et al. (Molecular cancer, 2024)
Keywords: Angiogenesis; Anlotinib; Antibodies; Biomarker; Biomarkers; Cancer; Cancer therapies; Care and treatment; Cell culture; Cell cycle; Cell growth; Cell proliferation; Chemotherapy; circRNAs; Circular RNA; Clinical trials; Colorectal cancer; Colorectal carcinoma; Drugs; Ethics; Health aspects; Hybridization; Kinases; Medical colleges; Medical research; Medicine, Experimental; Metastasis; Molecular biology; Molecular modelling; Mortality; Nuclear transport; Organoids; Patients; Plasmids; Proteins; RNA sequencing; Transcriptomes; Translation; Tumor proteins; Tumors; Tyrosine kinase inhibitors; Xenografts; China; United States--US; circRNAs; Anlotinib; Biomarker; Translation; Colorectal cancer